Hormone replacement therapy reduces mean 24-hour blood pressure and its variability in postmenopausal women with treated hypertension

Menopause

Volumn 7, Issue 1, 2000, Pages 31-35

  Szekacs, Bela ^a   Vajo, Zoltan ^b   Acs, Nandor ^a   Hada, Piroska ^a   Csuzi, Laszlo ^a   Bezeredi, Janos ^a   Magyar, Zoltan ^c   Brinton, Eliot A ^b  

^a SEMMELWEIS UNIVERSITY   (Hungary)

^b CARL T HAYDEN VA MEDICAL CENTER   (United States)

^c SEMMELWEIS UNIVERSITY   (Hungary)

Author keywords

Calcium channel blocker; Hormone replacement therapy; Hypertension

Indexed keywords

ANTIHYPERTENSIVE AGENT; CALCIUM CHANNEL; CALCIUM CHANNEL BLOCKING AGENT; ESTRADIOL; NORGESTREL;

ARTICLE; BLOOD PRESSURE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HORMONAL THERAPY; HORMONE ACTION; HORMONE SUBSTITUTION; HUMAN; HYPERTENSION; SYSTOLIC BLOOD PRESSURE;

EID: 0033958052     PISSN: 10723714     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042192-200007010-00006     Document Type: Article

References (24)

1. Corrao JM, Becker RC, Ockene IS, Hamilton GA. Coronary heart disease risk factors in women. Cardiology 1990;77(Suppl 2):8-24.
2. Rowland M, Roberts J. Blood pressure levels of persons 6-74 years: United States 1976-1980. National Health and Nutrition Examination Survey II. NCHS advance data (Vital and Health Statistics of the National Center for Health Statistics. No. 84). Washington, DC: US Department of Health and Human Services.
3. Staessen J, Bulpitt CJ, Fagard R, Lijnen P, Amery A. The influence of menopause on blood pressure. J Hum Hypertens 1989;3:427-33.
4. Bonithon-Kopp C, Scarabin PY, Darne B, Malmejac A, Guize L. Menopause-related changes in lipoproteins and some other cardiovascular risk factors. Int J Epidemiol 1990;19:42-8.
5. Posner BM, Cupples LA, Miller DR, Cobb JL, Lutz KJ, D' Agostino RB. Diet, menopause, and serum cholesterol levels in women: the Framingham Study. Am Heart J 1993;125(2 Pt 1):483-9.
6. Karas RH, Patterson BL, Mendelsohn ME. Human vascular smooth muscle cells contain functional estrogen receptor. Circulation 1994;89(5):1943-50.
7. Polderman KH, Stehouwer CD, van Kamp GJ, Dekker GA, Verheugt FW, Gooren LJ. Influence of sex hormones on plasma endothelin levels. Ann Intern Med 1993;118:429-32.
8. Weiner CP, Lizasoain I, Baylis SA, Knowles RG, Charles IG, Moncada S. Induction of calcium-dependent nitric oxide synthases by sex hormones. Proc Natl Acad Sci U S A 1994;91(11):5212-6.
9. Veille JC, Li P, Eisenach JC, Massmann AG, Figueroa JP. Effects of estrogen on nitric oxide biosynthesis and vasorelaxant activity in sheep uterine and renal arteries in vitro. Am J Obstet Gynecol, 1996;174(3):1043-9.
10. Han SZ, Karaki H, Ouchi Y, Akishita M, Orimo H. 17 beta-estradiol inhibits Ca2+ influx and Ca2+ release induced by thromboxane A2 in porcine coronary artery. Circulation 1995;91(10):2619-26.
11. Hall PM. Hypertension in women. Cardiology 1990;77(Suppl 2):25-30.
12. Schunkert H, Danser AH, Hense HW, Derkx FH, Kurzinger S, Riegger GA. Effects of estrogen replacement therapy on the reninangiotensin system in postmenopausal women. Circulation 1997;95(1):39-45.
13. Campbell DJ. Differential regulation of angiotensin peptides in plasma and kidney: effects of adrenalectomy and estrogen treatment. Clin Exp Hypertens 1997;19(5-6):687-98.
14. Wren BG. Blood pressure. Effects of estrogen and management of hypertension in women. In: Lobo RA, ed. Treatment of the postmenopausal women. New York: Raven Press, 1994:283-5.
15. Samaan SA, Crawford MH. Estrogen and cardiovascular function after menopause. J Am Coll Cardiol 1995;26(6):1403-10.
16. Dallongeville J, Marecaux N, Isorez D, Zylbergberg G, Fruchart JC, Amouyel P. Multiple coronary heart disease risk factors are associated with menopause and influenced by substitutive hormonal therapy in a cohort of French women. Atherosclerosis 1995;118(1):123-33.
17. van Ittersum FJ, van Baal WM, Kenemans P, et al. Ambulatory-not office-blood pressures decline during hormone replacement therapy in healthy postmenopausal women. Am J Hypertens 1998;11:1147-52.
18. Pelter MM, Adams MG, Wung SF, Paul SM, Drew BJ. Peak time of occurrence of myocardial ischemia in the coronary care unit. Am J Crit Care 1998;7(6):411-7.
19. Elliott WJ. Circadian variation in the timing of stroke onset: a metaanalysis. Stroke 1998;29(5):992-6.
20. Kakucs R, Varbiro S, Szekacs B, Nadasy GL, Acs N, Monos E. Direct relaxing effect of estradiol-17beta and progesterone on rat saphenous artery. Microvasc Res 1998;56(2):139-43.
21. Duckles SP, Krause DN, Miller VM. Effects of gonadal steroids on vascular function. Pharmacol Exp Ther 1996;279(1):1-3.
22. Barton M, Wright E, Dai-Do D, et al. Vascular protection with estrogen: in-vitro and in-vivo effects-mechanisms and clinical implication. Schweiz Rundsch Med Prax 1997;86(5):129-37.
23. Mancia G, Giannattasio C, Turrini D, Grassi G, Omboni S. Structural cardiovascular alterations and blood pressure variability in human hypertension. J Hypertens Suppl 1995;13(2):S7-14.
24. Punzi HA. Why ambulatory blood pressure monitoring? Am J Health Syst Pharm 1998;55(Suppl 3):S12-6.